MiFERT&i is a unique and innovative test offering a comprehensive analysis of the endometrium. It combines precise identification of the implantation window using advanced transcriptomic technologies with a detailed study of the endometrial tissue’s immunological and microbiological profiles.
This complete assessment provides critical insights into endometrial function and its ability to support embryo implantation, making it an essential tool for personalized fertility treatments and assisted reproduction.
The endometrial environment plays a crucial role in female fertility. Studies show that approximately 30% of cases involving unexplained infertility, recurrent implantation failure, or recurrent pregnancy loss may be linked to altered endometrial receptivity, immunological imbalances, or suboptimal endometrial microbiota.
Factors such as asymptomatic infections, persistent inflammation, or a displaced implantation window can impair the uterus’s capacity to receive the embryo. MiFERT&i addresses these factors comprehensively, offering a complete analysis that enables personalized intervention to improve outcomes in assisted reproduction treatments.
Helps determine the endometrial phase to optimize embryo transfer
Women with unexplained infertility.
Women with recurrent implantation failure.
Inflammatory
Normal
Post-receptive
Helps assess the immunological profile of the endometrium and analyze potential inflammatory or autoimmune abnormalities
Helps assess the status of the endometrial microbiome and analyze potential imbalances.
Women with unexplained infertility
Women with recurrent implantation failure
Women with recurrent pregnancy loss
Women with autoimmune-related disorders
Inflammatory
Normal
Immunosenescent
Cytotoxic / Angiogenic
Nos ayuda a determinar en qué fase
se encuentra el endometrio: para
poder optimizar la transferencia embrionaria
⇒ Mujeres que padezcan esterilidad por causa desconocida
⇒ Mujeres que hayan sufrido fallos
recurrentes de implantación
⇒ Inflamatorio
⇒ Normal
⇒Post receptivo
Nos ayuda a conocer como se
encuentra el endometrio a nivel
inmunologico y analizar sus
posibles alteraciones inflamatorias o autoinmunes
⇒ Mujeres que padezcan esterilidad por causa desconocida
⇒ Mujeres que hayan sufrido fallos
recurrentes de implantaciónç
⇒ Mujeres que hayan sufrido perdidas recurrentes de embarazo.
⇒ Mujeres que tengan alteraciones
relacionadas con la autoinmunidad
⇒ Inflamatorio
⇒ Normal
⇒ Inmunocenescente
⇒ Citóxico Angiogénico
Nos ayuda a conocer cómo se
encuentra el endometrio a nivel
inmunológico y analizar su posibles alteraciones.
⇒ Mujeres que sufren vaginosis recurrente.
⇒ Esterilidad de causa desconocida.
⇒ Fallos de implantación.
⇒ Abortos de repetición.
⇒ Patógenos
⇒ IL – Índice de Lactobacillus
⇒TL – Tipificación de Lactobacillus
To perform MiFERT&i, an endometrial tissue sample is required, obtained via a biopsy performed by a specialized healthcare professional. The sample must be collected in a specific tube and preserved under appropriate temperature conditions to maintain its integrity until analysis.
Once the risk is identified, preventive therapy using oral anticoagulants can be administered to block the formation of new thrombi and control existing ones. This treatment must be prescribed and supervised by a hematologist.
Incorporating MiFERT&i as part of a personalized approach in reproductive medicine allows for the detection of alterations in endometrial receptivity, immunological profile, and microbiota before they affect embryo implantation.
Its use is particularly indicated for women with recurrent implantation failure, unexplained infertility, a history of early pregnancy loss, or those about to start assisted reproduction treatments such as IVF or ICSI.
